[go: up one dir, main page]

AU2012360935A1 - Tablets and dry-coated agents - Google Patents

Tablets and dry-coated agents Download PDF

Info

Publication number
AU2012360935A1
AU2012360935A1 AU2012360935A AU2012360935A AU2012360935A1 AU 2012360935 A1 AU2012360935 A1 AU 2012360935A1 AU 2012360935 A AU2012360935 A AU 2012360935A AU 2012360935 A AU2012360935 A AU 2012360935A AU 2012360935 A1 AU2012360935 A1 AU 2012360935A1
Authority
AU
Australia
Prior art keywords
inner core
tablet
valsartan
dry
outer layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012360935A
Other languages
English (en)
Inventor
Masaki Ando
Takanori Ichihashi
Sayaka KOJIMA
Masato Sakurai
Rina TANAKA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2011284027A external-priority patent/JP2013133291A/ja
Priority claimed from JP2011284036A external-priority patent/JP2013133292A/ja
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2012360935A1 publication Critical patent/AU2012360935A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2012360935A 2011-12-26 2012-12-21 Tablets and dry-coated agents Abandoned AU2012360935A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2011284027A JP2013133291A (ja) 2011-12-26 2011-12-26 錠剤
JP2011284036A JP2013133292A (ja) 2011-12-26 2011-12-26 有核剤
JP2011-284036 2011-12-26
JP2011-284027 2011-12-26
PCT/EP2012/076794 WO2013098268A2 (fr) 2011-12-26 2012-12-21 Comprimés et agents enrobés à sec

Publications (1)

Publication Number Publication Date
AU2012360935A1 true AU2012360935A1 (en) 2014-07-17

Family

ID=47436010

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012360935A Abandoned AU2012360935A1 (en) 2011-12-26 2012-12-21 Tablets and dry-coated agents

Country Status (8)

Country Link
EP (1) EP2797580A2 (fr)
JP (1) JP2015504878A (fr)
KR (1) KR20140108652A (fr)
AU (1) AU2012360935A1 (fr)
BR (1) BR112014015620A8 (fr)
MX (1) MX2014007933A (fr)
RU (1) RU2014130743A (fr)
WO (1) WO2013098268A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI690333B (zh) * 2015-06-29 2020-04-11 日商大賽璐股份有限公司 易服用性固態製劑（有核錠）之製造方法及易服用性固態製劑
CA3201490A1 (fr) * 2020-11-13 2022-05-19 Sila Srl Compose dispersible par voie orale contenant un ester ou un sel d'acide n-butyrique et procede de production
CN112807286A (zh) * 2021-01-20 2021-05-18 海南皇隆制药股份有限公司 一种缬沙坦分散片制备方法和缬沙坦分散片
CN112826806A (zh) * 2021-01-20 2021-05-25 海南皇隆制药股份有限公司 一种缬沙坦片制备方法和缬沙坦片
JP7698962B2 (ja) * 2021-03-19 2025-06-26 三栄源エフ・エフ・アイ株式会社 不快風味のマスキング方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97219A (en) 1990-02-19 1995-12-08 Ciba Geigy Ag Biphenyl substituted aliphatic amino compounds process for their preparation and pharmaceutical compositions containing them
DE69331839T2 (de) 1992-01-29 2002-12-12 Takeda Chemical Industries, Ltd. Schnellösliche Tablette und ihre Herstellung
PT745382E (pt) 1994-01-31 2004-04-30 Yamanouchi Pharma Co Ltd Forma moldada por compressao com solubilidade intra-oral e processo para a sua producao
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
CA2311734C (fr) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Forme pharmaceutique orale a dissolution ultra-rapide
CN1284532C (zh) * 2001-09-28 2006-11-15 株式会社三和化学研究所 有核型速溶崩解性成型品
WO2007052307A2 (fr) * 2005-10-31 2007-05-10 Lupin Limited Formes posologiques solides orales stables de valsartan
PE20080991A1 (es) * 2006-06-27 2008-09-05 Novartis Ag Formas de dosificacion solidas de valsartan, amlodipina e hidroclorotiazida y metodo para elaborarlas
AR066168A1 (es) * 2007-09-28 2009-07-29 Novartis Ag Formulaciones galenicas de compuestos organicos
JP2009114113A (ja) * 2007-11-06 2009-05-28 Nipro Corp 口腔内崩壊錠及びその製造方法
US20100267787A1 (en) * 2007-11-12 2010-10-21 Gregory Harasymiw Pharmaceutical Compositions
JP5296456B2 (ja) * 2008-08-26 2013-09-25 大日本住友製薬株式会社 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
WO2010065489A1 (fr) * 2008-12-02 2010-06-10 Sciele Pharma, Inc. Composition d’agoniste alpha2-adrénergique et d’antagoniste de récepteur d’angiotensine ii
WO2010146551A2 (fr) * 2009-06-16 2010-12-23 Ranbaxy Laboratories Limited Compositions à désintégration orale comprenant des agents anti-hypertensifs
JP2013023463A (ja) * 2011-07-20 2013-02-04 Ohara Yakuhin Kogyo Kk 生理活性物質含有粒子の製造方法

Also Published As

Publication number Publication date
BR112014015620A2 (pt) 2017-06-13
MX2014007933A (es) 2014-07-30
WO2013098268A2 (fr) 2013-07-04
KR20140108652A (ko) 2014-09-12
EP2797580A2 (fr) 2014-11-05
BR112014015620A8 (pt) 2017-07-04
JP2015504878A (ja) 2015-02-16
RU2014130743A (ru) 2016-02-20
WO2013098268A3 (fr) 2013-08-22

Similar Documents

Publication Publication Date Title
EP2043637B1 (fr) Procédés et médicaments destinés à l'administration d'ibuprofène
AU2004246837B2 (en) Orally-dispersible multilayer tablet
US20040247677A1 (en) Multilayer orodispersible tablet
JP2019147844A (ja) 有効性が増加したアスピリン製剤
AU2012360935A1 (en) Tablets and dry-coated agents
US20080021078A1 (en) Methods and medicaments for administration of ibuprofen
JP5769853B2 (ja) テガフール、ギメラシル、オテラシルカリウム含有有核錠
US8999384B2 (en) Immediate release compositions of acid labile drugs
US20080020040A1 (en) Unit dose form for administration of ibuprofen
JP2010241760A (ja) 不快な味の軽減された口腔内速崩壊錠及びその製造方法
WO2010087358A1 (fr) Nouvelle composition
JP2005097277A (ja) 歯ぎしりの予防剤または治療剤
HK1211481A1 (en) Dry pressed coating tablet containing tegafur, gimeracil and oteracil potassium
US20150224056A1 (en) Pharmaceutical compositions of ibuprofen and famotidine
JP4355703B2 (ja) 歯ぎしりの予防剤または治療剤
CA3235787A1 (fr) Methodes de traitement de patients atteints de diabete de type 1 avec de l'eflornithine
JP2013133291A (ja) 錠剤
WO2021172462A1 (fr) Composition médicamenteuse et procédé visant à favoriser la récupération post-opératoire du tractus gastro-intestinal
JP2013133292A (ja) 有核剤
HK1180584B (en) Dry pressure coated tablet containing tegafur, gimeracil, oteracil potassium
HK1169038A (en) Compositions comprising famotidine and ibuprofen as well as compositions comprising 25 mg to 28 mg famotidine

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted